DV

DeciBio Ventures

Description

DeciBio Ventures is a venture capital firm.

Investor Profile

DeciBio Ventures has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Therapeutics.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does DeciBio Ventures frequently co-invest with?

Lansdowne Partners
Europe, England, United Kingdom, London
Co-Investments: 1
Salt Ventures
Asia, Sumatera Utara, Indonesia, Senayan
Co-Investments: 1
Kohlberg Kravis Roberts
North America, New York, United States, Hudson
Co-Investments: 1
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
OMX Ventures
North America, Illinois, United States, Lincolnshire
Co-Investments: 1
Axial VC
North America, California, United States, San Francisco
Co-Investments: 1

What are some of recent deals done by DeciBio Ventures?

Replay

San Diego, California, United States

Replay is a genome writing company reprogramming biology by writing and delivering big DNA.

BiotechnologyTherapeutics
Series AJul 25, 2022
Amount Raised: $55,000,000